Target intelligence / Profile preview

Rotavirus VP4 spike protein (RIX4414 strain) (VP4)

Target
VP4
Molecular classification
Viral attachment protein, Capsid protein, Antigen
01

Overview

The Rotavirus VP4 spike protein is a critical structural component of the rotavirus virion, specifically the RIX4414 strain used in live-attenuated vaccines. It functions as the viral attachment protein, forming 60 dimeric spikes that project from the outer capsid to mediate host cell recognition and entry [1: UniProt P12473]. For the virus to become infectious, VP4 must be proteolytically cleaved by trypsin-like enzymes into two subunits, VP8* and VP5*, which facilitate binding to cell surface receptors and subsequent membrane penetration [2: PubMed 22554309]. In the RIX4414 strain, which is a human G1P isolate, the VP4 protein is the primary determinant of the P-genotype and a major target for neutralizing antibodies [3: WHO Position Paper]. The therapeutic relevance of this protein lies in its role as a vaccine antigen; the Rotarix vaccine (RIX4414) utilizes this protein to elicit a protective immune response, primarily through the production of IgA antibodies that block viral attachment to intestinal enterocytes [4: PubMed 17484215]. Consequently, it is central to preventing severe rotavirus-induced gastroenteritis, a leading cause of childhood diarrhea worldwide [5: GSK Rotarix Prescribing Information].

Other names
Outer capsid protein VP4Spike protein VP4Protease-cleaved hemagglutininP proteinVP4 (RIX4414)
02

Mechanism of action

Induction of neutralizing antibodies (primarily IgA) that bind to the VP4 spikes, preventing viral attachment and entry into host enterocytes.

03

Biological functions

Viral attachmentCell entryMembrane penetrationHost cell binding
04

Disease associations

Rotavirus infectionGastroenteritis
05

Safety considerations

IntussusceptionVaccine-derived virus sheddingReversion to virulence
06

Interacting drugs

1 more in the full profile.

07

Biomarkers

Anti-rotavirus IgASerum neutralizing antibody titers

Beyond the preview

Go deeper on Rotavirus VP4 spike protein (RIX4414 strain) (VP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus VP4 spike protein (RIX4414 strain) (VP4).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call